1[1]Matrisian LM. The matrix- degrading metalloproteinases [J].Bioessays, 1992, 14:455-463.
2[2]Takino T, Sato H, Shinagawa A, et al. Identification of the second membrane- type matrix metalloproteriaiesgene from a human placente cDNA[J]. J Biol Chem, 1995, 270:23013 - 23020.
3[3]Murawaki Y, Ikuta Y, Kawasaki H. Serum matrix metalloproteinawe-1 in patients with chronic viral hepatitis[J] .J Gastroenterol Hepatol, 1999, 14(2):138- 145.
4[4]Murawaki Y, Ikuta Y, Idobe Y, et al. Tissue inhibitor of metalloproteinase - 1 in the liver of patients with chronic liver disease[ J]. J Hepatol, 1997, 26(6): 1213 - 1219.
5[5]Murawaki Y, Ikuta Y, Okamoto K. Serum matrix metalloproteinase - 3 (stromelysin - 1 ) concentration in patients with chronic liver disease[J] .J Hepatol, 1999, 31(3) :474- 481.
6[6]Kasahara A, Hayashi N, Mochizuki K, et al. Circulating matrix metalloproteinase - 2 and tissue inhibitor of metalloproteinase- 1 as serum markers of fibrosis in patients with chronic hepatitis C Relationship to interferon response[ J]. J Hepatol, 1997, 26(3 ): 574 -583.
7[7]Nakamura - T, Ushiyama - C, Suzuki - S. Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis[J]. Blood Purif,2000, 18(11):50-54.
